Jian Xiao
Guangdong Provincial People's Hospital · Sixth Affiliated Hospital, Sun Yat-sen University · Peking University Third Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jian Xiao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:25 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07722754 · Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 TrialGuangdong Provincial People's Hospital · recruiting · Colorectal Neoplasms Malignant, Neoplasm, Metastatic · principal investigator
- Ph2NCT05342389 · Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric CancerSixth Affiliated Hospital, Sun Yat-sen University · unknown · Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma · principal investigator
- N/ANCT04986462 · Arthroscopic Treatment of Bursal-side Rotator Cuff Tears in Shoulder JointPeking University Third Hospital · completed · Rotator Cuff Tears · principal investigator
- N/ANCT04960449 · Arthroscopic Treatment of Partial Rotator Cuff Tears in Shoulder JointPeking University Third Hospital · completed · Rotator Cuff Tears · principal investigator
- Ph2NCT04840264 · Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel ObstructionSixth Affiliated Hospital, Sun Yat-sen University · recruiting · Metastatic Gastric Adenocarcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis · study chair
- Ph2NCT04547153 · Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICSixth Affiliated Hospital, Sun Yat-sen University · completed · Gastric Cancer, Bone Marrow Metastasis, Disseminated Intravascular Coagulation · study chair
- Ph2NCT04358341 · Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric CancerSixth Affiliated Hospital, Sun Yat-sen University · unknown · Gastric Cancer · principal investigator
- Ph3NCT04358354 · Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric CancerSixth Affiliated Hospital, Sun Yat-sen University · unknown · Metastatic Gastric Cancer · principal investigator
- Ph3NCT03961867 · Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric AdenocarcinomaSixth Affiliated Hospital, Sun Yat-sen University · unknown · Gastric Cancer · principal investigator
- Ph2NCT01552967 · Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal AdenocarcinomaSixth Affiliated Hospital, Sun Yat-sen University · unknown · Colorectal Adenocarcinoma · principal investigator
- Ph2NCT01552980 · Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric AdenocarcinomaSixth Affiliated Hospital, Sun Yat-sen University · unknown · Gastric Adenocarcinoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 12:25 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- 67 citationsRCR 2.2
- 54 citationsRCR 3.9
- 40 citationsRCR 2.8
- Effect of electrically stimulating acupoint, Zusanli (ST 36), on patient's recovery after laparoscopic colorectal cancer resection: a randomized controlled trial.J Tradit Chin Med · 201934 citationsRCR 2.4
- Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer.Clin Colorectal Cancer · 201932 citationsRCR 1.1
- Population pharmacokinetics of humanized monoclonal antibody HuCC49deltaCH2 and murine antibody CC49 in colorectal cancer patients.J Clin Pharmacol · 200725 citationsRCR 0.8
- 22 citationsRCR 2.5
- Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.Cancer Biother Radiopharm · 200520 citationsRCR 0.6
- Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.Phytomedicine · 202420 citationsRCR 3.2
- Sandwich-like neoadjuvant therapy with bevacizumab for locally advanced rectal cancer: a phase II trial.Cancer Chemother Pharmacol · 201515 citationsRCR 0.5